A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder
- 30 September 2008
- journal article
- clinical trial
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 18 (9), 639-645
- https://doi.org/10.1016/j.euroneuro.2008.04.011
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trialEuropean Neuropsychopharmacology, 2007
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Randomized dose‐ranging pilot trial of omega‐3 fatty acids for postpartum depressionActa Psychiatrica Scandinavica, 2005
- Omega-3 Eicosapentaenoic Acid in Bipolar DepressionPublished by Physicians Postgraduate Press, Inc ,2005
- Omega-3 fatty acids for the prevention of postpartum depression: Negative data from a preliminary, open-label pilot studyDepression and Anxiety, 2004
- Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trialEuropean Neuropsychopharmacology, 2003
- ResolvinsThe Journal of Experimental Medicine, 2002
- Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive DisorderAmerican Journal of Psychiatry, 2002
- Descriptive and Inferential StatisticsPublished by Elsevier BV ,1998
- The changing rate of major depression. Cross-national comparisons. Cross-National Collaborative GroupJAMA, 1992